A Pilot Study to Explore the Role of Gut Flora in Psoriasis

Withdrawn before enrolling

Conditions studied: Psoriasis, Psoriasis Vulgaris, Psoriasis Universalis, Psoriasis Face, Psoriasis Nail, Psoriatic Plaque, Psoriasis Diffusa, Psoriasis Punctata, Psoriasis Palmaris, Psoriasis Circinata, Psoriasis Annularis, Psoriasis Genital, Psoriasis of Scalp, Psoriasis Geographica

In brief

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Psoriasis.

Key facts

Study ID

NCT04099979

Run by

ProgenaBiome

People needed

0

Starts

2020-03-02

Expected to finish

2030-07-01

Last updated by the study team

2025-06-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed informed consent by patient
• Male or female patients age 18 and older.
• Diagnosis of Psoriasis based on PSAI of greater than or equal to 12 at screening

You may not qualify if…

• Refusal by patient to sign informed consent form
• Treatment with antibiotics within 2 weeks prior to screening
• Treatment with probiotics within 6 weeks prior to screening
• History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
• Postoperative stoma, ostomy, or ileoanal pouch
• Participation in any experimental drug protocol within the past 12 weeks
• Treatment with total parenteral nutrition
• Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
• Inability of patient to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study

Where it is running

• ProgenaBiome — Ventura, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.